Author Question: A researcher designs a study to determine if a new teaching modality will benefit a particular group ... (Read 44 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
A researcher designs a study to determine if a new teaching modality will benefit a particular group of special education students that she has been working with. Which of the designs would this researcher be most likely to use?
 
  A) Comparison between two or more groups
  B) Comparison of one group's status at two or more points in time
  C) Comparison of one group's status under different circumstances
  D) Comparison based on relative rankings

Question 2

When there are multiple authors of a report, the lead author:
 
  A) Is always listed as the first author
  B) Is the person whose name is first alphabetically
  C) Is the person who has overall responsibility for the manuscript
  D) None of the above



ryrychapman11

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

C

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library